Panagiota Economopoulou
Overview
Explore the profile of Panagiota Economopoulou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
86
Citations
1319
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Economopoulou P, Pantazopoulos A, Spathis A, Kotsantis I, Kyriazoglou A, Kavourakis G, et al.
Cells
. 2022 Jan;
11(1).
PMID: 35011594
Background: nasopharyngeal carcinoma (NPC) is a complex disease entity that mainly predominates in endemic regions. Real-world data with immunotherapy from nonendemic regions are limited. Methods: we collected data from patients...
22.
Gavrielatou N, Economopoulou P, Kotsantis I, Psyrri A
Front Oncol
. 2021 Dec;
11:815763.
PMID: 34938666
No abstract available.
23.
Gavrielatou N, Vathiotis I, Economopoulou P, Psyrri A
Cancers (Basel)
. 2021 Nov;
13(21).
PMID: 34771546
Head and neck cancer comprises a heterogenous, highly immune infiltrated malignancy, defined by a predominantly immunosuppressive tumor microenvironment (TME). In recent years, PD-1/PD-L1 immune checkpoint inhibitors have become the standard...
24.
A personalized approach to pancreatic ductal adenocarcinoma and its application in surgical practice
Schizas D, Koumpoura A, Galari M, Economopoulou P, Vailas M, Sotiropoulou M, et al.
Per Med
. 2021 Oct;
18(6):613-627.
PMID: 34676789
Pancreatic duct adenocarcinoma is an aggressive tumor which constitutes the fourth leading cause of cancer-related mortality in the USA. Despite the fact that surgery is an integral part of treatment,...
25.
Economopoulou P, Kotsantis I, Psyrri A
Viruses
. 2021 Sep;
13(9).
PMID: 34578368
HPV-related head and neck squamous cell carcinoma (HNSCC) has emerged as a diverse clinical and biological disease entity, mainly in young patients with oropharyngeal tumors who are nonsmokers and nondrinkers....
26.
Economopoulou P, Chrysikopoulou A, Goula K, Papiri I, Psyrri A, Kotsantis I, et al.
Case Rep Oncol
. 2021 Jun;
13(3):1281-1284.
PMID: 34191931
Breast metastasis originating from non-mammary tumors is an uncommon event accounting for 0.5-6.6% of all breast neoplasms. The primary malignancies that reportedly metastasize to the breast most frequently are hematologic...
27.
Gazouli I, Kyriazoglou A, Kotsantis I, Anastasiou M, Pantazopoulos A, Prevezanou M, et al.
Cancers (Basel)
. 2021 Apr;
13(8).
PMID: 33917001
Osteosarcoma is the most frequent primary bone cancer, mainly affecting those of young ages. Although surgery combined with cytotoxic chemotherapy has significantly increased the chances of cure, recurrent and refractory...
28.
Economopoulou P, Kotsantis I, Psyrri A
Immunotherapy
. 2021 Apr;
13(9):723-726.
PMID: 33910385
No abstract available.
29.
Moutafi M, Economopoulou P, Rimm D, Psyrri A
Oral Oncol
. 2021 Apr;
117:105292.
PMID: 33862558
Poly (ADP-ribose) polymerase (PARP) inhibitors (PARPi) have revolutionized the treatment landscape in several cancers. PARPi increase DNA damage particularly in tumors with underlying defects in DNA repair. In addition to...
30.
Economopoulou P, Anastasiou M, Papaxoinis G, Spathas N, Spathis A, Oikonomopoulos N, et al.
Cancers (Basel)
. 2021 Jan;
13(2).
PMID: 33466719
: We sought to compare patterns of response to immune checkpoint inhibitors (ICI) with respect to clinical and genomic features in a retrospective cohort of patients with recurrent/metastatic (R/M) head...